We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Proton Versus Photon Beam Radiotherapy in the Treatment of Head and Neck Cancer

This study is currently recruiting participants.
Verified October 2017 by Memorial Sloan Kettering Cancer Center
Sponsor:
ClinicalTrials.gov Identifier:
NCT02923570
First Posted: October 4, 2016
Last Update Posted: October 16, 2017
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
Collaborator:
Mayo Clinic
Information provided by (Responsible Party):
Memorial Sloan Kettering Cancer Center
  Purpose
Compared to IMRT, PBRT is thought to give less radiation exposure to the surrounding healthy tissues. It is possible that side effect rates with PBRT will be lower or the same compared to IMRT, but this has not been well studied to date. Although both of these radiation therapies have been used in the past to treat head and neck cancer, this research study will compare the effects of these two different radiation treatment modalities with each other to see whether PBRT is better, the same or worse than IMRT.

Condition Intervention Phase
Head and Neck Cancer Radiation: Photon intensity modulated radiation therapy (IMRT) Radiation: Proton beam radiotherapy (PBRT) Phase 2

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Phase II Randomized Study of Proton Versus Photon Beam Radiotherapy in the Treatment of Unilateral Head and Neck Cancer

Resource links provided by NLM:


Further study details as provided by Memorial Sloan Kettering Cancer Center:

Primary Outcome Measures:
  • number of patients with grade 2 or greater acute mucositis [ Time Frame: 1 year ]
    via the CTCAE v4.0.


Estimated Enrollment: 132
Actual Study Start Date: October 3, 2016
Estimated Study Completion Date: October 2021
Estimated Primary Completion Date: October 2021 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: Photon intensity modulated radiation therapy (IMRT)
IMRT to standard dose of 60-66Gy
Radiation: Photon intensity modulated radiation therapy (IMRT)
Experimental: Proton beam radiotherapy (PBRT)
PBRT to standard dose of 60-66Gy
Radiation: Proton beam radiotherapy (PBRT)

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Age greater than or equal to 18.
  • Histopathologically confirmed diagnosis of one the following cancer types:

    • Salivary gland cancer without the presence of extracapsular extension and/or positive surgical margin.
    • Skin cancer
    • Melanoma
  • Patients must be a candidate for ipsilateral radiation therapy.
  • Karnofsky performance status ≥70.
  • Negative pregnancy test for women of childbearing potential (<51 years of age) as per institutional policy.

Exclusion Criteria:

  • Any prior head or neck irradiation.
  • Physician recommendation of bilateral neck radiation.
  • Non-resectable disease
  • Physician recommendation of mucosal radiation
  • Use of chemotherapy
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02923570


Contacts
Contact: Nancy Lee, MD 212-639-3341
Contact: Oren Cahlon, MD 212-639-5219

Locations
United States, Minnesota
Mayo Clinic Not yet recruiting
Rochester, Minnesota, United States, 55905
Contact: Robert Foote, MD    507-284-2511      
Principal Investigator: Robert Foote, MD         
United States, New Jersey
Memorial Sloan Kettering Cancer Center at Basking Ridge Recruiting
Basking Ridge, New Jersey, United States
Contact: Nancy Lee, MD    212-639-3341      
Memorial Sloan Kettering Monmouth Recruiting
Middletown, New Jersey, United States, 07748
Contact: Nancy Lee, MD    212-639-3341      
United States, New York
Memorial Sloan Kettering Cancer Center at Commack Recruiting
Commack, New York, United States, 11725
Contact: Nancy Lee, MD    212-639-3341      
Memorial Sloan Kettering Westchester Recruiting
Harrison, New York, United States, 10604
Contact: Nancy Lee, MD    212-639-3341      
Memorial Sloan Kettering Cancer Center Recruiting
New York, New York, United States, 10065
Contact: Nancy Lee, MD    212-639-3341      
Contact: Oren Cahlon, MD    212-639-5219      
Principal Investigator: Nancy Lee, MD         
Memorial Sloan Kettering Cancer Center at Mercy Medical Center Recruiting
Rockville Centre, New York, United States, 11570
Contact: Nancy Lee, MD    212-639-3341      
Sponsors and Collaborators
Memorial Sloan Kettering Cancer Center
Mayo Clinic
Investigators
Principal Investigator: Nancy Lee, MD Memorial Sloan Kettering Cancer Center
  More Information

Additional Information:
Responsible Party: Memorial Sloan Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT02923570     History of Changes
Other Study ID Numbers: 16-1416
First Submitted: October 3, 2016
First Posted: October 4, 2016
Last Update Posted: October 16, 2017
Last Verified: October 2017

Keywords provided by Memorial Sloan Kettering Cancer Center:
proton-beam radiation therapy (PBRT)
intensity-modulated radiation therapy (IMRT)
16-1416

Additional relevant MeSH terms:
Head and Neck Neoplasms
Neoplasms by Site
Neoplasms